Found 4,563 investors
Khulasande Capital

Khulasande Capital

South Africa

Khulasande Capital is a black-owned and controlled private equity and investment firm. Khulasande is dedicated to the growth of South Africa through Broad-Based Black Economic Empowerment (BBBEE).
Private Equity Firm

Khulisa Investment Partners

South Africa

Khulisa Investment Partners is a private equity firm that exists to make a difference to the South African economy by providing funding to businesses typically underserved by financial institutions and by facilitating a transfer of wisdom to the next generation of business leaders in the country. It focuses on impact investment and addressing the UN Sustainable Development Goals. Creating maximum value, through both financial and social impact, from each investment. It is based in Newlands, South Africa.
Private Equity Firm
Kildare Enterprises

Kildare Enterprises

United States

Founded in 2003, Kildare Enterprises is a private equity firm based in Bernards Township, New Jersey. The firm prefers to invest in growth-stage companies through buyouts. The firm seeks to invest in business products, business services, and manufacturing sectors.
Private Equity Firm

Kim Cooke

France

Mr. Philippe Tramoy serves as Partner at Seventure Partners. He is a Member of the Strategic Advisory Board of Keen Eye. He also serves as Borad Member at Scipio Bioscience.He is a Board Member of CBDMT. He serves as Board Member at PEP-Therapy. Previously, he was the Managing Partner and Founder of CBDMT, a Partner with InnoTune EEIG, and the Business Development Manager of Europe with Rodia Chriz-Rhodia Pharma Solutions.
Individual/Angel
Kimen Til Vekst

Kimen Til Vekst

Norway

Kimen Til Vekst is a venture capital firm that is based in Hemsedal, Norway. The firm main aim is to contribute to increased value creation in Hallingdal and Valdres through business and development measures.
Venture Capital

Kim Shriver

Atlanta, Georgia, United States

Kim Shriver
Investment Partner

Kim Väisänen

United States

Mr. Brian Beard serves as Chief Legal Officer at Colossal Biosciences. He is a Co-Founder and serves as Chief Legal Officer at Colossal. He serves as Chief Global Legal Officer and Board Member at Hypergiant. He served as a Partner at Wilson Sonsini Goodrich & Rosati. He joined the firm from the Austin office of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, which he co-founded in 1997. He practices corporate and securities law with a focus on the representation of start-up and emerging growth companies, representation of issuers and underwriters involved in public offerings, and representation of companies involved in merger and acquisition transactions. He helped build one of the leading technology practices in Texas, assisting emerging growth companies to raise billions of dollars in private and public offerings. He also has handled several billion dollars in mergers and acquisitions transactions and has represented leading venture capital firms in Texas and throughout the country. He helps facilitate strategic company growth and execute the long-term vision of the company with speed and precision including the various partnerships and licensing. Over the span of his 35+ year legal career, including 15 years as managing partner of Wilson Sonsini Goodrich Rosati, he has served as outside corporate counsel to public and private companies, advising them on a wide range of significant corporate transactions, including mergers and acquisitions, initial public offerings, and private equity and venture capital financings. He has successfully orchestrated and closed thousands of technology transactions as well as hundreds of public offerings for companies and underwriters. In addition to his legal role, he has advised a number of management teams and Boards of Directors on their corporate strategy, with a focus on corporate governance issues.
Individual/Angel

Kim Wennerholm

United Kingdom

Mr. Ian Nolan serves as Co-Founding Partner and Chair of Investment Committee at Circularity Capital. He also serves as Board Member at PackBenefit, P2i and Switchee. He also serves as Independent Non-Executive Chairman and Investment Committee Chairman at Greensphere Capital. He serves as Non-Executive Director at Albion Community Power. Mr. Nolan served as Senior Advisor at Alexa Capital. He has three decades' experience in finance, private equity, and investment management. Mr. Nolan was most recently Chief Investment Officer of the UK Green Investment Bank between 2012 and 2014 having started his career at 3i Group in 1987 becoming Chief Investment Officer in 2009 with responsibility for managing £10 billion of assets. He has a diverse range of global equity and debt investment experience that includes the infrastructure and alternative energy sectors and was also a member of various of 3i Group's executive and risk management committees, including the Executive Committee, Investment Committee, Risk Committee, and Conflicts Committee. In 2012 he set up the UK Green Investment Bank and was the Chief Investment Officer through 2014. Since its inception, the bank has mobilized £5 billion into the UK alternative energy sector. He qualified as a chartered accountant with Arthur Andersen and graduated with a BA in Economics from Cambridge University. He served as Board Member at Breezie and advisor.
Individual/Angel

Kindmore

United States

Mr. Matthew Christensen is a Co-Founder and serves as Chief Executive Officer & Managing Partner at Rose Park Advisors. He serves as a Board Member at Tava Health. He served as Board Member at BioLite and SyncOnSet Technologies. He also serves as Board Member at CircleUp Network, Activate Care and LeasePilot. He serves as a Board Observer at Fetch Package. Prior to Rose Park, he was a strategy consultant at Innosight and the Boston Consulting Group. He serves as the Chairman at Astoria Solutions. He holds a BSE in Civil Engineering from Duke University and an MBA from Harvard Business School.
Individual/Angel

Kingdom Investments

United Arab Emirates

Kingdom Investments is a private equity firm based in Dubai, United Arab Emirates. The firm seeks to invest through means of buyouts and growth capital. The firm also makes venture capital investments in later-stage, early-stage, and seed-stage companies. The firm prefers to invest in recreational goods, retail, healthcare, financial services, software and real estate sectors.
Private Equity Firm

Kiwibank FinTech Accelerator

Wellington, Wellington, New Zealand

The Kiwibank Fintech Accelerator is a three-month business growth programme.
Accelerator
KKCG

KKCG

Switzerland

KKCG is a private investment group that actively seeks projects with hidden investment potential. The firm relies on three stable pillars KKCG Oil & Gas, KKCG Entertainment & Technologies, and KKCG Investments. The third, KKCG Investments, provides the basis for investments with long-term growth potential. Another sector in the target is real estate, where the company executes architectural projects that provide a stable yield. It was founded in 1999 and is headquartered in Lucerne, Switzerland.
Private Equity Firm

Klas Johansson

United States

Mr. Walter Nimmo is an angel investor. He served as Advisor at Scottish Equity Partners. Walter Nimmo founded Inveresk Clinical Research in 1998 as an independent Scottish clinical contract research organization. As a self funded start-up, Nimmo led Inveresk through a period of strong growth before merging it with, and subsequently re-purchasing it from, SGS. By 1999, Inveresk had revenues of £42 million and a staff of more than 600. In 2002, as chief executive, Nimmo listed Inveresk on NASDAQ with a valuation of $600 million. Two years later, he merged it with Charles River Laboratories, a transaction which valued Inveresk at $1.5 billion. Nimmo was non-executive vice chairman of Charles River Laboratories until 2005. He is on the board of directors at Aberforth Smaller Companies Trust and several private companies. He is an honorary professor at the University of Edinburgh Medical School. He was Scottish Entrepreneur of the Year 2002 and Edinburgh Alumnus of the Year 2003.
Individual/Angel
Klaus Decker Ihr Büro für Wirtschaftsdienste

Klaus Decker Ihr Büro für Wirtschaftsdienste

Maxstraße 38, 45479 Mülheim an der Ruhr, Germany

Investment service

Klinco

Mexico City, Distrito Federal, Mexico

Provides financial education and personal financial management through an APP.
Micro VC Venture Capital
Kline Hawkes & Co

Kline Hawkes & Co

Los Angeles, California, United States

Kline Hawkes & Co., manages through its funds, Kline Hawkes California, Kline Hawkes California SBIC, L.P.
Finance Financial Exchanges Venture Capital Venture Capital

Knut Hellandsvik

United States

Mr. Christopher Fong is an Angel Investor.
Individual/Angel

Koau Capital Partners

New Zealand

Koau Capital Partners is a venture capital firm headquartered in Christchurch, New Zealand with a regional office based in Wellington, New Zealand.
Venture Capital

Kohan Ventures

United States

Mr. Lavigne served as Board Member at Puppet and BMC Software. Mr. Lavigne serves as a Director at DocuSign. He is managing director of Lavrite, LLC and former Executive Vice President and Chief Financial Officer of Genentech Inc., leads DocuSign's Audit and Finance Committee. He brings decades of corporate finance, accounting, growth strategy and IT management experience to DocuSign's board. In his twenty-three years at Genentech, he led the company's financial, corporate relations and information technology groups as revenues grew from $40 million in 1983 to $300 million in 1988 when he became CFO to more than $6.5 billion in 2005 when he was named 'Best CFO in Biotech' by Institutional Investor. Mr. Lavigne is a Chairman and Member of the Board of Directors of Accuray, Inc. (Chairman of the Board & Compensation Committee), Allergan, Inc. (Member of the Audit and Finance & Science and Technology Committees), BMC Software (Chairman of the Audit Committee & Member of the M&A Committee), Depomed, Inc. (Audit Committee member), NovoCure (Audit Committee Chairman) and SafeNet, Inc. (Audit Committee Chairman). Previously, he was a Director and Chairman of the Audit Committee of several other public companies including Arena Pharmaceuticals, Equinix, Kyphon and Genova. Mr. Lavigne is also part of the Pacific SW Audit Committee Network of Audit Committee Chairs and Deloitte's Life Sciences Advisory Board. Mr. Lavigne is the managing member of Spring Development Group, LLC, a strategic investor in companies with unique growth opportunities. Mr. Lavigne is a board member and former Chairman of the UCSF Benioff Children's Hospitals. Mr. Lavigne is also a member of the West Coast Audit Committee Network and the faculty of the GLG Institute. He also served as Chairman of the Children's Hospital & Research Center Foundation. He serves as Board Member at Zynga.
Individual/Angel
Konnex Communities

Konnex Communities

Vienna, Wien, Austria

Coworkingspaces Schraubenfabrik and Rochus Park.
Communities Incubators Co-Working Space
Showing 3041 to 3060 of 4,563 results